Macrogenics (MGNX) Enterprise Value (2012 - 2026)

Macrogenics (MGNX) has 15 years of Enterprise Value data on file, last reported at -$66.5 million in Q1 2026.

• On a quarterly basis, Enterprise Value rose 54.31% year-over-year to -$66.5 million in Q1 2026; TTM through Mar 2026 was -$66.5 million, a 54.31% increase from a year earlier, with the FY2025 full-year figure at -$57.2 million, up 68.71% from the prior year.
• Enterprise Value for Q1 2026 stood at -$66.5 million, down from -$57.2 million in the prior quarter.
• Over the last five years, Enterprise Value for MGNX reached as high as -$21.5 million in Q2 2022 and fell as low as -$224.3 million in Q1 2023.
• Historically, Enterprise Value has averaged -$105.4 million across 5 years, with a median of -$89.9 million in 2023.
• Across the five-year window, Enterprise Value surged 88.64% in 2022 and slumped 406.58% in 2023, its largest moves.
• Year by year, Enterprise Value stood at -$108.9 million in 2022, then gained by 7.28% to -$101.0 million in 2023, then plunged by 81.11% to -$182.8 million in 2024, then surged by 68.71% to -$57.2 million in 2025, then retreated by 16.25% to -$66.5 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$66.5 million in Q1 2026, -$57.2 million in Q4 2025, and -$80.1 million in Q3 2025.